166 related articles for article (PubMed ID: 34626574)
1. Vitreoretinal Lymphoma: Optimizing Diagnostic Yield and Accuracy.
Santos MC; Jiang A; Li AS; Rao PK; Wilson B; Harocopos GJ
Am J Ophthalmol; 2022 Apr; 236():120-129. PubMed ID: 34626574
[TBL] [Abstract][Full Text] [Related]
2. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
[TBL] [Abstract][Full Text] [Related]
3. PreservCyt Is an Optimal Fixative that Permits Cytologic and Molecular Analyses of Vitreoretinal Lymphoma Biopsies.
Wang MM; Tan WJ; Lim TS; Chan ASY
Ocul Immunol Inflamm; 2021 Apr; 29(3):430-439. PubMed ID: 31418635
[No Abstract] [Full Text] [Related]
4. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
[TBL] [Abstract][Full Text] [Related]
5. More Accurate Diagnosis of Vitreoretinal Lymphoma Using a Combination of Diagnostic Test Results: A Prospective Observational Study.
Tanaka R; Kaburaki T; Taoka K; Karakawa A; Tsuji H; Nishikawa M; Yatomi Y; Shinozaki-Ushiku A; Ushiku T; Araki F
Ocul Immunol Inflamm; 2022 Aug; 30(6):1354-1360. PubMed ID: 33793360
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic efficacy of cell block method for vitreoretinal lymphoma.
Kase S; Namba K; Iwata D; Mizuuchi K; Kitaichi N; Tagawa Y; Okada-Kanno H; Matsuno Y; Ishida S
Diagn Pathol; 2016 Mar; 11():29. PubMed ID: 26987877
[TBL] [Abstract][Full Text] [Related]
7. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
[No Abstract] [Full Text] [Related]
8. Next-Generation Sequencing of Vitreoretinal Lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation.
Kwak JJ; Lee KS; Lee J; Kim YJ; Choi EY; Byeon SH; Chang WS; Kim YR; Kim JS; Shin S; Lee ST; Kim SS; Lee CS
Invest Ophthalmol Vis Sci; 2023 Nov; 64(14):27. PubMed ID: 37975847
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives.
Kaburaki T; Taoka K
Jpn J Ophthalmol; 2023 Jul; 67(4):363-381. PubMed ID: 37209195
[TBL] [Abstract][Full Text] [Related]
10. Logistic regression models of cytokines in differentiating vitreoretinal lymphoma from uveitis.
Tian S; Chen K; Xiao J; Zhou X; Shi H; Li Y; Huang H; Ma Y; Chen B; Wang Q; Guan M
J Clin Lab Anal; 2022 Oct; 36(10):e24689. PubMed ID: 36098043
[TBL] [Abstract][Full Text] [Related]
11. Single B-Cell Genomic Analyses Differentiate Vitreoretinal Lymphoma from Chronic Inflammation.
Tan WJ; Wang MM; Castagnoli PR; Tang T; Chan ASY; Lim TS
Ophthalmology; 2021 Jul; 128(7):1079-1090. PubMed ID: 33221324
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of intraocular lymphoma by polymerase chain reaction analysis and cytokine profiling of the vitreous fluid.
Sugita S; Takase H; Sugamoto Y; Arai A; Miura O; Mochizuki M
Jpn J Ophthalmol; 2009 May; 53(3):209-14. PubMed ID: 19484437
[TBL] [Abstract][Full Text] [Related]
13. Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes.
Levasseur SD; Wittenberg LA; White VA
JAMA Ophthalmol; 2013 Jan; 131(1):50-5. PubMed ID: 23307208
[TBL] [Abstract][Full Text] [Related]
14. Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology Center.
Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Porcu P; Martinez NL; Glass J; Mashayekhi A; Shields CL
Asia Pac J Ophthalmol (Phila); 2020; 9(2):110-116. PubMed ID: 31923035
[TBL] [Abstract][Full Text] [Related]
15. The challenge in the diagnosis and management of vitreoretinal lymphoma.
Habot-Wilner Z; Pe'er J; Frenkel S
Clin Exp Ophthalmol; 2023 Mar; 51(2):107-109. PubMed ID: 36789671
[No Abstract] [Full Text] [Related]
16. Vitreous proteomics, a gateway to improved understanding and stratification of diverse uveitis aetiologies.
Schrijver B; Kolijn PM; Ten Berge JCEM; Nagtzaam NMA; van Rijswijk ALCT; Swagemakers SMA; van der Spek PJ; Missotten TOAR; van Velthoven MEJ; de Hoog J; van Hagen PM; Langerak AW; Dik WA
Acta Ophthalmol; 2022 Jun; 100(4):403-413. PubMed ID: 34318583
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiling of vitreous fluid by massively parallel sequencing: a case series.
Hirschhorn JW; Snider JS; Lindsey KG; Schandl CA
J Am Soc Cytopathol; 2020; 9(4):254-257. PubMed ID: 32423686
[TBL] [Abstract][Full Text] [Related]
18. Primary vitreoretinal lymphoma: empowering our clinical suspicion.
Takhar JS; Doan TA; Gonzales JA
Curr Opin Ophthalmol; 2019 Nov; 30(6):491-499. PubMed ID: 31589186
[TBL] [Abstract][Full Text] [Related]
19. Logistic Regression Classification of Primary Vitreoretinal Lymphoma versus Uveitis by Interleukin 6 and Interleukin 10 Levels.
Kuo DE; Wei MM; Knickelbein JE; Armbrust KR; Yeung IYL; Lee AY; Chan CC; Sen HN
Ophthalmology; 2020 Jul; 127(7):956-962. PubMed ID: 32197914
[TBL] [Abstract][Full Text] [Related]
20.
Narasimhan S; Joshi M; Parameswaran S; Rishi P; Khetan V; Ganesan S; Biswas J; Sundaram N; Sreenivasan J; Verma S; Krishnamurthy V; Subramanian K
Indian J Ophthalmol; 2020 Oct; 68(10):2160-2165. PubMed ID: 32971631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
